These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32534823)

  • 1. Non-invasive prenatal testing: A diagnostic innovation shaped by commercial interests and the regulation conundrum.
    Löwy I
    Soc Sci Med; 2022 Jul; 304():113064. PubMed ID: 32534823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
    Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
    BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.
    Lund ICB; Petersen OB; Becher NH; Lildballe DL; Jørgensen FS; Ambye L; Skibsted L; Ernst A; Jensen AN; Fagerberg C; Brasch-Andersen C; Tabor A; Zingenberg HJ; Nørgaard P; Almind GJ; Vestergaard EM; Vogel I
    Acta Obstet Gynecol Scand; 2021 May; 100(5):884-892. PubMed ID: 33230826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.
    Xiao G; Zhao Y; Huang W; Hu L; Wang G; Luo H
    PLoS One; 2022; 17(4):e0266718. PubMed ID: 35421148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
    Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
    BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.
    Bedei I; Wolter A; Weber A; Signore F; Axt-Fliedner R
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study.
    Lewis C; Hill M; Chitty LS
    PLoS One; 2016; 11(4):e0153147. PubMed ID: 27045195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.
    Ngan OMY; Yi H; Ahmed S
    BMC Health Serv Res; 2018 Sep; 18(1):731. PubMed ID: 30241520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.